GlassScriptPhysician profile
Justin Lobello
NPI 1912376435
$2,732.46
in general payments reported to CMS, 2019-2025
35 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $504 · 2021: $253 · 2022: $218 · 2023: $498 · 2024: $496 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $287.55 | 2019-2020 | |
| Smith+Nephew, INC. | $281.77 | 2020-2024 | Grafix Pl, Collagenase Santyl |
| Djo, LLC | $238.70 | 2020-2024 | Cmf |
| Paratek Pharmaceuticals, INC. | $167.42 | 2021-2025 | Nuzyra |
| Wright Medical Technology, INC. | $142.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $132.71 | 2022-2023 | Seglentis |
| Treace Medical Concepts, INC. | $125.00 | 2019 | |
| Ibsa Pharma INC. | $125.00 | 2024 | Licart |
| Orthofix Medical, INC. | $124.14 | 2020-2025 | Physio-Stim, Accelstim |
| Medtronic Vascular, INC. | $105.84 | 2020 | |
| Melinta Therapeutics, LLC | $92.82 | 2019 | |
| Medtronic, INC. | $82.89 | 2023 | Hawkone |
| Zyla Life Sciences, INC. | $75.06 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $73.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.73 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $70.36 | 2021-2023 | Ortholoc 2 Lapifuse |
| Medimetriks Pharmaceuticals, INC. | $65.67 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.78 | 2020-2023 | Jublia |
| Kerecis Limited | $53.37 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Alfasigma USA, INC. | $38.41 | 2021 | |
| Nevro Corp. | $37.62 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.69 | 2025 | |
| Bioventus LLC | $30.43 | 2019-2021 | |
| Acumed LLC | $25.66 | 2023 | |
| Osteomed LLC | $25.51 | 2020 | |
| Tactile Systems Technology INC | $23.41 | 2022 | |
| Horizon Therapeutics Plc | $19.20 | 2020 | |
| Mimedx Group, INC. | $19.09 | 2024 | |
| Heron Therapeutics, INC. | $18.48 | 2022 | |
| Sebela Pharmaceuticals INC. | $18.09 | 2021 | |
| Amgen INC. | $15.46 | 2024 | Krystexxa |
| Mayne Pharma Commercial LLC | $14.88 | 2022 | |
| Integra Lifesciences Corporation | $11.23 | 2019 | |
| Sandoz INC. | $11.05 | 2020 | |
| Glenmark Therapeutics INC. | $9.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Lobello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.